Benjamin T Dake

CIK 1869248 · View on SEC EDGAR ↗

Insider

First SEC filing: June 29, 2021 · Latest: June 29, 2021

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 3 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 29, 2021 JBIO A 180,800 180,800 Direct Acquired (price as of 2026-08-19)
April 2, 2021 JBIO A 48,882 48,882 Direct Acquired (price as of 2026-08-19)
April 2, 2021 JBIO A 328,921 328,921 Direct Acquired (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 29, 2021 JBIO Stock Option (Right to Buy) Common Stock (180,800) $14.00 June 28, 2031 180,800 Acquired
April 2, 2021 JBIO Stock Option (Right to Buy) Common Stock April 1, 2031 48,882 Acquired
April 2, 2021 JBIO Stock Option (Right to Buy) Common Stock April 1, 2031 328,921 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 4 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
June 29, 2021 JBIO Stock Option (Right to Buy)→ Common Stock (48,293) 48,293 Direct
June 29, 2021 JBIO Stock Option (Right to Buy)→ Common Stock (72,325) 72,325 Direct
June 29, 2021 JBIO Stock Option (Right to Buy)→ Common Stock (48,882) 48,882 Direct
June 29, 2021 JBIO Stock Option (Right to Buy)→ Common Stock (328,921) 328,921 Direct